Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Joints »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Joint Diseases < Joints < Jurkat Cells  Facettes :

List of bibliographic references indexed by Joints

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000D20 (2019) Han Joo Baek [Corée du Sud] ; Mie Jin Lim [Corée du Sud] ; Won Park [Corée du Sud] ; Sung Hwan Park [Corée du Sud] ; Seung-Cheol Shim [Corée du Sud] ; Dae-Hyun Yoo [Corée du Sud] ; Hyun Ah Kim [Corée du Sud] ; Soo Kon Lee [Corée du Sud] ; Yun Jong Lee [Corée du Sud] ; Young Eun Park [Corée du Sud] ; Hoon-Suk Cha [Corée du Sud] ; Yeong-Wook Song [Corée du Sud]Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis.
001239 (2018) Xavier M. Teitsma [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas]Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies.
001560 (2017) Cosimo Bruni [Italie] ; Emanuela Praino [Italie] ; Yannick Allanore [France] ; Oliver Distler [Suisse] ; Armando Gabrielli [Italie] ; Florenzo Iannone [Italie] ; Marco Matucci-Cerinic [Italie]Use of biologics and other novel therapies for the treatment of systemic sclerosis.
001610 (2017) Gerd R. Burmester [Allemagne] ; William F. Rigby [États-Unis] ; Ronald F. Van Vollenhoven [Suède] ; Jonathan Kay [États-Unis] ; Andrea Rubbert-Roth [Allemagne] ; Ricardo Blanco [Espagne] ; Alysha Kadva [États-Unis] ; Sophie Dimonaco [Royaume-Uni]Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
001684 (2017) Muznay N. Khawaja [États-Unis] ; Martin J. Bergman [États-Unis] ; Jeffrey Yourish [États-Unis] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Edward Keystone [Canada]Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
001967 (2016) Tsuyoshi TakedaTreatment strategy of elderly rheumatoid arthritis.
001B67 (2016) Maarten Boers [Pays-Bas] ; Daniel Aletaha ; Christopher M. Mela ; Daniel G. Baker ; Josef S. SmolenGlucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.
001C00 (2016) Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Anne Sofie Siebuhr [Danemark] ; Claus Christiansen [Danemark] ; Inger Byrjalsen [Danemark] ; Morten A. Karsdal [Danemark]Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study
001F58 (2015) Torsten Witte [Allemagne]Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
002026 (2015) Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi KumanogohExpansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
002028 (2015) Maxime Dougados ; Tom W. J. Huizinga ; Ernest H. Choy ; Clifton O. Bingham ; Maher Aassi ; Corrado BernasconiEvaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial
002158 (2015) Takeshi Suzuki [Japon] ; Tomoya Hirota [Japon] ; Hiroshi Ogishima [Japon] ; Naoto Umeda [Japon] ; Yuya Kondo [Japon] ; Masahiro Yokosawa [Japon] ; Haruka Miki [Japon] ; Hiroto Tsuboi [Japon] ; Isao Matsumoto [Japon] ; Takayuki Sumida [Japon]Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years
002317 (2014) Philip G. Conaghan [Royaume-Uni] ; Charles Peterfy ; Ewa Olech ; Jeffrey Kaine ; David Ridley ; Julie Dicarlo ; Josh Friedman ; Jenny Devenport ; Orrin TroumThe effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.
002351 (2014) Anne C. Bay-Jensen [Royaume-Uni] ; Inger Byrjalsen [Royaume-Uni] ; Anne Sofie Siebuhr [Royaume-Uni] ; Claus Christiansen [Royaume-Uni] ; Adam Platt [Royaume-Uni] ; Morten A. Karsdal [Royaume-Uni]Serological Biomarkers of Joint Tissue Turnover Predict Tocilizumab Response at Baseline
002456 (2014) Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi ; Koichi Amano ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Shunsuke Fukuyo ; Hideto Kameda ; Yuko Kaneko ; Takahiko Kurasawa ; Hayato Nagasawa ; Daisuke Hoshi ; Eri Sato ; Hisashi YamanakaEffect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
002457 (2014) Niels Graudal [Danemark] ; Thorbj Rn Hubeck-Graudal [Danemark] ; Simon Tarp [Danemark] ; Robin Christensen [Danemark] ; Gesche Jürgens [Danemark]Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
002483 (2014) Oscar Epis [Italie] ; Emilio Filippucci ; Andrea Delle Sedie ; Anna De Matthaeis ; Eleonora BruschiClinical and ultrasound evaluation of the response to tocilizumab treatment in patients with rheumatoid arthritis: a case series.
003386 (2013) Roy M. Fleischmann [États-Unis, Afrique du Sud, Pologne, Mexique, Royaume-Uni] ; Anne-Marie Halland ; Marek Brzosko ; Ruben Burgos-Vargas ; Christopher Mela ; Emma Vernon ; Joel M. KremerTocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results
003487 (2012) John M. Davis [États-Unis] ; Eric L. MattesonMy treatment approach to rheumatoid arthritis.
003499 (2012) Fabiola Atzeni [Royaume-Uni] ; Donatella Ventura ; Alberto Batticciotto ; Laura Boccassini ; Piercarlo Sarzi-PuttiniInterleukin 6 blockade: tocilizumab in psoriatic arthritis.
003552 (2012) Josef S. Smolen [Autriche] ; José C Martinez Avila [Autriche] ; Daniel Aletaha [Autriche]Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Joints" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Joints" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Joints
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021